logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-38. Table TDI-38: Clients in treatment by primary drug, all types of treatment centre, 2007 or most recent year available [see all tables in this series...]

Part (iii) Percentage of clients injecting their primary drug by country, primary drug and incidence/prevalence

CountryOpioids Cocaine/CrackAmphetamine
YearFirst treatment incidenceTotal treatment incidenceTreatment prevalenceFirst treatment incidenceTotal treatment incidenceTreatment prevalenceFirst treatment incidenceTotal treatment incidenceTreatment prevalence
Austria200728.447.842.71.59.68.52.41.30.6
Bulgaria200773.281.584.0:::0.00.00.0
Croatia2007:::::::::
Cyprus200762.969.867.10.05.25.50.00.00.0
Czech Republic200732.783.984.20.00.00.075.780.481.0
France200713.325.822.44.513.211.70.010.010.4
Hungary200666.0:60.37.8:11.716.7:18.2
Ireland2007:::::::::
Italy200650.960.574.410.09.77.011.315.428.8
Latvia2007::91.8::0.0::70.3
Malta2006::65.8::29.1::0.0
Netherlands20075.25.16.10.10.30.80.21.82.0
Poland2006:::::::::
England2006/07:::::::::
Total46.452.562.08.38.35.959.570.458.1

Notes:

 First treatment incidence = Clients entering drug treatment for the first time in their life 

 Total treatment incidence = Clients entering drug treatment during the year (clients entering treatment for the first time in their lives and clients entering treatment who have been in treatment in previous years)  

 Treatment prevalence = All clients in treatment (clients entering treatment for the first time in their lives, clients entering treatment who have been in treatment in previous years and clients who continued in treatment from the previous year)  

Sources:

 2008 voluntary data collection on treatment Prevalence - pilot project on treatment prevalence             

(see the help page for information about formats etc.)

Page last updated: Thursday, 30 June 2011